Observational Non-interventional Study About Antiretroviral Combination Treatment With Aptivus in Combination With Low-dose Ritonavir in HIV Type 1 Infected Patients.
Phase of Trial: Phase IV
Latest Information Update: 03 Jun 2014
At a glance
- Drugs Tipranavir (Primary) ; Ritonavir
- Indications HIV-1 infections
- Focus Adverse reactions
- Sponsors Boehringer Ingelheim
- 10 Jun 2017 Biomarkers information updated
- 14 May 2010 Actual end date (Jan 2009) added as reported by ClinicalTrials.gov.
- 03 Mar 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.